Inhibition of IL-1β reduces tumor growth in melanoma by attenuating inflammation and promoting MDSC towards M1 macrophage, which subsequently reduces angiogenesis through neutralized VEGF; however, when tumors relapse, the expression of HIF-1α in a paracrine manner has been found to allow angiogenesis to rebound. This evidence concerns the gene IL1B and melanoma.